To include your compound in the COVID-19 Resource Center, submit it here.

EVP-6124: Phase IIb data

Top-line data from a double-blind, international Phase IIb trial in 319 chronic schizophrenia patients on stable second-generation antipsychotics showed that once-daily 0.3 and

Read the full 238 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE